Atrivita ApS: Financial statements 2025
CVR: 42734233
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Atrivita ApS (CVR 42734233) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,618,949 and a net result of DKK 635,955 compared with DKK 290,857 the year before. That is an increase of 316.1% compared with the year before. Equity in the 2025 report amounted to DKK 1,495,144. The solvency ratio was 61.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,618,949
- Profit/Loss
- DKK 635,955
- Equity
- DKK 1,495,144
- Total Assets
- DKK 2,435,101
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.6M | 636K | 1.5M | 1 |
| 2024 | - | 389K | 291K | 859K | 0 |
| 2023 | - | 607K | 469K | 568K | 0 |
Official annual report
How creditworthy is Atrivita ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Atrivita ApS has published its annual report for 2024. Gross profit came to DKK 389,121, and the net result was DKK 290,857.
About Atrivita ApS
Atrivita ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2021. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MedPro Health ApS. The management consists of Bo Tandrup. The board consists of Ivan Berkes (chair). The company is owned by COMMERCE PHARMA HOLDING ApS and London Pharma Capital Limited. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 1,618,949 and a net result of DKK 635,955 compared with DKK 290,857 the year before. Equity in the 2025 report amounted to DKK 1,495,144.